If the blood community had a motto, it might be close to that of Scouting America’s: Be Prepared. That is why planning, preparedness, risk assessment and risk reduction for “Disease X” are always top of mind for the experts and organizations tasked with ensuring a safe and sufficient blood supply during the next emerging pathogen event.
“We are judged not on how well we do day to day, but during the emergencies,” said Jed Gorlin, MD, MBA, transfusion service medical director at Hennepin County Medical Center. “People may get annoyed that we are constantly saying ‘donate blood,’ but it is essential to have blood on the shelf. Any time blood is transfused in an emergency, it is blood that was donated at least several days before the emergency occurred. Preparedness is what we are all about.”
Natural and human factors, such as climate change, human expansion and air travel, are creating an environment more capable than ever to support the next global emerging human pathogen event, and the risk for next emerging infectious disease (EID) is greater than ever. In fact, the World Health Organization has reported that since the 1970s, approximately 40 new infectious diseases have been discovered, including COVID-19, Zika, avian influenza and more.1 At the same time, risk for re-emerging diseases — such as measles and tuberculosis — has also increased.2 Fortunately, there are more tools than ever to help prepare for the next EID.
BACK TO ISSUE
May 2026NEXT STORY
Ensuring Optimal Blood Safety at All Times
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Jose Cancelas, MD, PhD, CABP
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
